Description: Eucrates Biomedical Acquisition Corp. operates as a blank Check company focusing on acquiring, engaging in a share exchange, share reconstruction and amalgamations. The company was founded by Stelios Papadopoulos, Parag Saxena, Evangelos Vergetis and Daphne Karydas on August 21, 2020 and is headquartered in New York, NY.
250 West 55th Street
New York,
NY
10019
United States
Phone:
212 710 5220
Officers
| Name | Title |
|---|---|
| Mr. Parag Phoolchand Saxena MBA, MS | CEO & Director |
| Dr. Evangelos Vergetis | Pres, COO & Director |
| Mr. Gonzalo Cordova CFA | Chief Financial Officer |
| Mr. Shrikant Sathe | Sr. VP |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 42.7778 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2020-10-23 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |